Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Expression of B7-H1, a costimulating glycoprotein in the B7 family, is normally restricted to macrophage-lineage cells, providing a potential costimulatory signal source for regulation of T cell activation. In contrast, aberrant expression of B7-H1 by tumor cells has been implicated in impairment of T cell function and survival, resulting in defective host antitumoral immunity. The relationship between tumor-associated B7-H1 and clinical cancer progression is unknown. Herein, we report B7-H1 expression by both renal cell carcinoma (RCC) tumors of the kidney and RCC tumor-infiltrating lymphocytes. In addition, our analysis of 196 clinical specimens reveals that patients harboring high intratumoral expression levels of B7-H1, contributed by tumor cells alone, lymphocytes alone, or tumor and/or lymphocytes combined, exhibit aggressive tumors and are at markedly increased risk of death from RCC. In fact, patients with high tumor and/or lymphocyte B7-H1 levels are 4.5 times more likely to die from their cancer than patients exhibiting low levels of B7-H1 expression (risk ratio 4.53; 95% confidence interval 1.94–10.56; P < 0.001.) Thus, our study suggests a previously undescribed mechanism whereby RCC may impair host immunity to foster tumor progression. B7-H1 may prove useful as a prognostic variable for RCC patients both pre- and posttreatment. In addition, B7-H1 may represent a promising target to facilitate more favorable responses in patients who require immunotherapy for treatment of advanced RCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Subsequent human studies have consistently shown that PD-L1 and PD-L2 expression not only increases in cancerous tissues but is also linked to poor disease prognosis in many cancer types (50)(51)(52)(53)(54)(55)(56).”
From Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance (2021) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Self-citationIwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Self-citationPhan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
The Heidelberg classification of renal cell tumours
Kovacs, G., Akhtar, M., Beckwith, B. J., Bugert, P., Cooper, C. S., Delahunt, B., Eble, J. N., Fleming, S., Ljungberg, B., Medeiros, L. J., et al. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2<131::aid-path931>3.0.co;2-g · Cited by 1,354
FRANK, I., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64153-5 · Cited by 1,175
Self-citationComparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma
Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L., & Blute, M. L. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00005 · Cited by 1,087
Self-citationHodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
THE CHANGING NATURAL HISTORY OF RENAL CELL CARCINOMA
PANTUCK, A. J., ZISMAN, A., & BELLDEGRUN, A. S. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65640-6 · Cited by 882
Classification of renal cell carcinoma: Workgroup No. 1
St�rkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., Darson, M., Delahunt, B., & Iczkowski, K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<987::aid-cncr24>3.0.co;2-r · Cited by 864
Self-citationRandomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer
Yang, J. C., Sherry, R. M., Steinberg, S. M., Topalian, S. L., Schwartzentruber, D. J., Hwu, P., Seipp, C. A., Rogers-Freezer, L., Morton, K. E., White, D. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.122 · Cited by 790
Blank, C., Brown, I., Peterson, A. C., Spiotto, M., Iwai, Y., Honjo, T., & Gajewski, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3259 · Cited by 772
Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H., & Ohtani, H. (2001) · PubMed · Cited by 639
B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
Strome, S. E., Dong, H., Tamura, H., Voss, S. G., Flies, D. B., Tamada, K., Salomão, D. R., Cheville, J. C., Hirano, F., Lin, W. Y., et al. (2003) · PubMed · Cited by 540
Self-citationWintterle, S., Schreiner, B., Mitsdoerffer, M., Schneider, D., Chen, L., Meyermann, R., Weller, M., & Wiendl, H. (2003) · PubMed · Cited by 381
Self-citationB7-H1 Determines Accumulation and Deletion of Intrahepatic CD8+ T Lymphocytes
Dong, H., Zhu, G., Tamada, K., Flies, D. B., van Deursen, J. M. A., & Chen, L. (2004) · Immunity · doi:10.1016/s1074-7613(04)00050-0 · Cited by 372
Self-citationSTAGE SPECIFIC GUIDELINES FOR SURVEILLANCE AFTER RADICAL NEPHRECTOMY FOR LOCAL RENAL CELL CARCINOMA
LEVY, D. A., SLATON, J. W., SWANSON, D. A., & DINNEY, C. P. N. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63541-9 · Cited by 351
B7-H1 pathway and its role in the evasion of tumor immunity
Dong, H., & Chen, L. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0430-2 · Cited by 276
Self-citationLjungberg, Alamdari, Rasmuson, & Roos (1999) · BJU International · doi:10.1046/j.1464-410x.1999.00202.x · Cited by 274
BUI, M. H. T., VISAPAA, H., SELIGSON, D., KIM, H., HAN, K.-R., HUANG, Y., HORVATH, S., STANBRIDGE, E. J., PALOTIE, A., FIGLIN, R. A., et al. (2004) · Journal of Urology · doi:10.1097/01.ju.0000116444.08690.e2 · Cited by 197
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H., Driscoll, C. L. W., & Chen, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16015 · Cited by 190
Self-citationBromwich, E. J., McArdle, P. A., Canna, K., McMillan, D. C., McNicol, A.-M., Brown, M., & Aitchison, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601400 · Cited by 162
Figlin, R. A., Pierce, W. C., Kaboo, R., Tso, C. L., Moldawer, N., Gitlitz, B., deKernion, J., & Belldegrun, A. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64304-0 · Cited by 160
Alexander, J. P., Kudoh, S., Melsop, K. A., Hamilton, T. A., Edinger, M. G., Tubbs, R. R., Sica, D., Tuason, L. J., Klein, E. A., & Bukowski, R. M. (1993) · PubMed · Cited by 153
Curti, B. D. (2004) · JAMA · doi:10.1001/jama.292.1.97 · Cited by 150
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
Uzzo, R. G., Rayman, P. A., Kolenko, V. M., Clark, P. E., Bloom, T., Ward, A. M., Moltó, L. M., Tannenbaum, C. S., Worford, L., Bukowski, R. M., et al. (1999) · PubMed · Cited by 145
Lohse, C. M., Blute, M. L., Zincke, H., Weaver, A. L., & Cheville, J. C. (2002) · American Journal of Clinical Pathology · doi:10.1309/vlv6-brtr-hy5b-h485 · Cited by 139
Self-citationNakagomi, H., Pisa, P., Pisa, E. K., Yamamoto, Y., Halapi, E. C., Backlin, K., Juhlin, C., & Kiessling, R. W. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630311 · Cited by 125
Ashcroft, G. S., Herrick, S. E., Tarnuzzer, R. W., Horan, M. A., Schultz, G. S., & Ferguson, M. W. J. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2<169::aid-path915>3.0.co;2-q · Cited by 117
Copland, J. A., Luxon, B. A., Ajani, L., Maity, T., Campagnaro, E. L., Guo, H., LeGrand, S. N., Tamboli, P., & Wood, C. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206835 · Cited by 101
Uhlman, D. L., Nguygen, P. L., Manivel, J. C., Aeppli, D. M., Resnick, J. M., Fraley, E. E., Zhang, G., & Niehans, G. A. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.19.1470 · Cited by 94
Prognostic value of ploidy and proliferation markers in renal cell carcinoma
Tannapfel, A., Hahn, H., Katalinic, A., Fietkau, R., Kühn, R., & Wittekind, C. W. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1<164::aid-cncr27>3.0.co;2-2 · Cited by 87
Li, X., Liu, J., Park, J., Hamilton, T. A., Rayman, P. A., Klein, E. A., Edinger, M., Tubbs, R., Bukowski, R. M., & Finke, J. H. (1994) · PubMed · Cited by 84
Scott, C., Nelson, J. S., Farnan, N. C., Curran, W. J., Murray, K. J., Fischbach, A. J., Gaspar, L. E., & Nelson, D. F. (1995) · Cancer · doi:10.1002/1097-0142(19950715)76:2<296::aid-cncr2820760221>3.0.co;2-l · Cited by 84
Lahn, M., Fisch, P., Köhler, G., Kunzmann, R., Hentrich, I., Jesuiter, H., Behringer, D. M., Muschal, B., Veelken, H., Kulmburg, P., et al. (1999) · European Urology · doi:10.1159/000019821 · Cited by 77
Chest wall resection in the treatment of locally recurrent breast carcinoma
Faneyte, I. F., Rutgers, E. J. T., & Zoetmulder, F. A. �. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970901)80:5<865::aid-cncr6>3.0.co;2-k · Cited by 70
SURGERY OF RENAL CELL CARCINOMA
Couillard, D. R., & White, R. D. (1993) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00485-7 · Cited by 70
Delahunt, B., Bethwaite, P. B., Nacey, J. N., & Ribas, J. L. (1993) · The Journal of Pathology · doi:10.1002/path.1711700411 · Cited by 68
Graham, S. D., Babayan, R. K., Dl, L., Sawczuk, I. S., Ross, S. D., Lavin, P. T., Osband, M. E., & Krane, R. J. (1993) · PubMed · Cited by 32
Shimazui, T., Oosterwijk, E., Akaza, H., Bringuier, P., Ruijter, E. T. G., van Berkel, H., Wakka, J. O., Bokhoven, A. V., Debruyne, F. M. J., & Schalken, J. A. (1998) · PubMed · Cited by 31
Motzer, R. J. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00062-3 · Cited by 31
Kudoh, S., Redovan, C., Rayman, P. A., Edinger, M., Tubbs, R. R., Novick, A. C., Finke, J. H., & Bukowski, R. M. (1997) · Journal of Immunotherapy · doi:10.1097/00002371-199711000-00008 · Cited by 28
Immunotherapy for Urological Malignancies
Krejci, K. G., Markiewicz, M. A., & Kwon, E. D. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000101161.17279.09 · Cited by 24
Self-citationTherneau, T. M., & Grambsch, P. M. (2000) · Statistics in the health sciences · doi:10.1007/978-1-4757-3294-8_5 · Cited by 16
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Dong, H., Strome, S. E., Matteson, E. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316015 · Cited by 16
Self-citationCostimulation-based immunotherapy for head and neck cancer
Strome, S. E., & Chen, L. (2004) · Current Treatment Options in Oncology · doi:10.1007/s11864-004-0003-9 · Cited by 12
Self-citationPRACTICE AND PROGRESS IN KIDNEY CANCER: METHODOLOGY FOR NOVEL DRUG DEVELOPMENT
Rini, B. I., WEINBERG, V. K., & Small, E. J. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000113728.46439.02 · Cited by 6
Research works printed but not linked: 11
- Strome, S.-E., Dong, H., Tamura, H., Voss, S.-G., Flies, D.-B., Tamada, K., Salomao, D., Cheville, J.-C, Hirano, F., Lin, W., et al. (2003) Cancer Res. 63, 6501–6505.14559843
- Graham, S., Babayan, R.-K., Lamm, D.-L., Sawczuk, I., Ross, S.-D., Lavin, P.-T., Osband, M.-E. & Krane, R.-J. (1993) Semin. Urol. 11, 27–34.8465126
- Krejci, K.-G., Markiewicz, M.-A. & Kwon, E.-D. (2003) J. Urol. 171, 870–876.
- Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H. & Ohtani, H. (2001) Cancer Res. 61, 5132–5136.11431351
- Wintterle, S., Schreiner, B., Mitsdoerffer, M., Schneider, D., Chen, L., Meyermann, R., Weller, M. & Wiendl, H. (2003) Cancer Res. 63, 7462–7467.14612546
- Uzzo, R.-G., Rayman, P., Kolenko, V., Clark, P.-E., Bloom, T., Ward, A.-M., Molto, L., Tannenbaum, C., Worford, L.-J, Bukowski, R.-M., et al. (1999) Clin. Cancer Res. 5, 1219–1229.10353760
- Alexander, J.-P., Kudoh, S., Melsop, K.-A., Hamilton, T.-A., Edinger, M.-G., Tubbs, R.-R., Sica, D., Tuason, L., Klein, E., Bukowski, R., et al. (1993) Cancer. Res. 53, 1380–1387.8443817
- Li, X., Liu, J., Park, J.-K., Hamilton, T.-A., Rayman, P., Klein, E., Edinger, M., Tubbs, R., Bukowski, R. & Finke, J. (1994) Cancer Res. 54, 5424–5429.7923175
- Kudoh, S., Redovan, C., Rayman, P., Edinger, M., Tubbs, R.-R., Novick, A., Finke, J.-H. & Bukowski, R.-M. (1997) J. Immunol. 20, 479–487.
- Motzer, R.-J. (2003) Crit. Rev. Oncol. Hematol. 46S, s33–s39.
- Shimazui, T., Oosterwijk, E., Akaza, H., Bringuier, P., Ruijter, E., van Berkel, H., Wakka, J.-O., van Bokhoven, A., Debruyne, F.-M. & Schalken, J.-A. (1998) Clin. Cancer Res. 4, 2419–2424.9796973
Cited by
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,400
Self-citationBagchi, S., Yuan, R., & Engleman, E. G. (2021) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042020-042741 · Cited by 2,189
Metadata
- Authors
- Thompson, R. H., Gillett, M. D., Cheville, J. C., Lohse, C. M., Dong, H., Webster, W. S., Krejci, K. G., Lobo, J. R., Sengupta, S., Chen, L., Zincke, H., Blute, M. L., Strome, S. E., Leibovich, B. C., & Kwon, E. D.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-29
- Volume
- 101
- Issue
- 49
- Pages
- 17174-17179
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC534606
- OpenAlex
- W4230861071
- Cited by
- 776
- References
- 48
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 29 · 2022: 32 · 2021: 42 · 2020: 51 · 2019: 60 · 2018: 57 · 2017: 76 · 2016: 65 · 2015: 69 · 2014: 57 · 2013: 29 · 2012: 28
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- PD-L1, renal cell carcinoma, tumor-infiltrating lymphocytes, tumor progression, prognostic factors, tumor immune evasion, T cell costimulation, immunotherapy targets, cancer mortality
- MeSH terms
- Carcinoma, Renal Cell, Follow-Up Studies, Humans, Immunity, Immunohistochemistry, Membrane Glycoproteins, Neoplasm Proteins, Peptides, Prognosis, Antigens, CD, Odds Ratio, Survival Analysis, Lymphocytes, Tumor-Infiltrating, B7-1 Antigen, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.